Media

Vicore Pharma publishes the Annual Report for 2022

Adcendo ApS Announces Extension of Series A financing to 82M EUR toEnsure Broad Development of its First-in-class ADC Pipeline

Carisma Therapeutics Reports Fiscal 2022 Financial Results and Recent Business Highlights

Vicore to announce AIR trial update at the ATS congress on May 21st

Doctrin receives ISO/IEC 27001 certification

Aprea Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Update on Business Operations

Vicore receives Innovation Passport designation by the UK regulatory agency MHRA for C21 in IPF

Oncopeptides receives a research grant from Sweden´s Innovation Agency to explore the PDC platform in solid tumors

Fusion Pharmaceuticals Announces First Patient Dosed In Phase 1 Study Of FPI-2059, A Targeted Alpha Therapy (TAT) For The Treatment Of Solid Tumors Expressing NTSR1

Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results And Clinical Program Updates